FDA Orange Book

Is there a generic for Zembrace Symtouch (autoinjector)?

Zembrace Symtouch (autoinjector) contains sumatriptan. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

No. The Orange Book lists no active FDA-approved generic (ANDA) for Zembrace Symtouch (autoinjector) (sumatriptan). The Orange Book shows its last listed patent expires January 29, 2036.

Run it in Rivvi

Map Zembrace Symtouch (autoinjector) and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Zembrace Symtouch (autoinjector) products in the Orange Book

Zembrace Symtouch (autoinjector) products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
solution, subcutaneousEQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)Marketed (Rx)None0None

NDA 208223, held by TONIX MEDICINES INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Zembrace Symtouch (autoinjector) patents

Patents listed for Zembrace Symtouch (autoinjector)
PatentExpiresCoversUse codeNDA
10537554January 29, 2036Method of useU-72208223
11364224January 29, 2036Method of useU-72208223
12097183January 29, 2036Drug productNone208223

Zembrace Symtouch (autoinjector) NDC codes

Questions

Is there a generic for Zembrace Symtouch (autoinjector)?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Zembrace Symtouch (autoinjector) (sumatriptan). The Orange Book shows its last listed patent expires January 29, 2036.

What is the generic name for Zembrace Symtouch (autoinjector)?

The active ingredient in Zembrace Symtouch (autoinjector) is sumatriptan, per the FDA Orange Book.

When does the Zembrace Symtouch (autoinjector) patent expire?

The last patent listed for Zembrace Symtouch (autoinjector) in the Orange Book expires January 29, 2036. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Zembrace Symtouch (autoinjector) and Sumatriptan

Try it on your own data today.

Free to start. Most teams are using it the same day.